A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles
Abstract
Authors
R.C. Fowler L.M. Street-Docherty S. Morrison